“We will evaluate how the commercialization of the substance suits in with our company product at Adastra in an effort to placement ourselves to aid the need for a secure provide of copyright,” explained Main executive officer Michael Forbes in a very information launch. The organization instructed VICE News it wouldn't be commenting further.co